Últimas noticias sobre Ontrak (NASDAQ:OTRK) Bolsa

Ontrak

Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.

Ontrak Inc

WIIM

SNCR

Synchronoss Technologies shares are trading higher after the company reported better-than-expected Q4 earnings and sales.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) from Neutral to Neutral.

News

Reiteration

Analyst Ratings

AGEN

HC Wainwright & Co. Reiterates Neutral on Agenusto Neutral

Rosenblatt analyst Mike Genovese maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Neutral and lowers the price target from $79 to $73.

Price Target

CIEN

Rosenblatt Maintains Neutral on Ciena, Lowers Price Target to $73

IRBT

iRobot shares are trading lower after the company disclosed substantial doubt about its ability to continue as a going concern.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Geron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) from Neutral to Neutral.

GERN

HC Wainwright & Co. Reiterates Neutral on Geronto Neutral

Heinz Launched Dip For Potato Chips, Same Unmistakable Ketchup, New Way To Enjoy

SFIX

Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.

GRPN

Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.

Needham analyst Ryan Koontz maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Buy and lowers the price target from $95 to $90.

Needham Maintains Buy on Ciena, Lowers Price Target to $90

Rosenblatt analyst Blair Abernethy upgrades Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) from Neutral to Buy and announces $77 price target.

Upgrades

RBRK

Rosenblatt Upgrades Rubrik to Buy, Announces $77 Price Target

TSLA

Tesla shares are trading higher after CEO Elon Musk on social media announced plans to double US vehicle production within two years.

Whitestone REIT Announced That It Has Signed A Lease With The Picklr To Open A 20,909-square-foot Location At Terravita Marketplace In Scottsdale, Arizona

STEC

Santech Holdings Regains NASDAQ Compliance, Closes Chapter On Minimum Bid Price Violation

TLRY

Tilray Beverages Announced The Distribution Expansion For Runner's High Brewing, Its Non-alcoholic Craft Beer Brand, Across 4,500 New Distribution Points

INTC: 9% &#x7C; <a href="https://www.benzinga.com//node/44271204">TSMC Proposes Joint Venture With Nvidia, AMD And Broadcom To Operate Intel's Factories: Report</a>
&nbsp;
GRPN: 27% &#x7C; <a href="https://www.benzinga.com//node/44262868">Groupon shares are trading higher after the company reported better-than-expected Q4 revenue results.</a>
&nbsp;
SFIX: 24% &#x7C; <a href="https://www.benzinga.com//node/44262293">Stitch Fix shares are trading higher following strong Q2 earnings and upbeat Q3 guidance.</a>

Movers

Trading Ideas

INTC

Market-Moving News for March 12th

Intel shares are trading higher following a report suggesting TSMC pitched a joint venture to Nvidia, AMD, Broadcom and Qualcomm to operate Intel's factories.

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) with a Buy and maintains $100 price target.

IMCR

HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

Q1 2025 Guidance
Given the prevailing uncertainty in NIH funding and academic research purchasing, along with normal seasonality, the Company expects Q1 2025 revenues of $19 million to $21 million and gross margin in the 56% to 58% range.

Guidance

HBIO

Harvard Bioscience Expects Q1 Revenue Of $19M-$21M Vs $22.95M Est

Piper Sandler analyst Derek Podhaizer assumes Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) with a Overweight rating and announces Price Target of $22.

Initiation

AESI

Piper Sandler Assumes Atlas Energy Solutions at Overweight, Announces Price Target of $22

HC Wainwright &amp; Co. analyst Sean Lee maintains Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) with a Buy and raises the price target from $7.5 to $9.5.

HC Wainwright & Co. Maintains Buy on Myomo, Raises Price Target to $9.5

Press Releases

Ontrak Health Demonstrates Significant Improvement in Members' Quality of Life from ReQoL Mental Health Assessment

Ontrak, Inc. Announces Reverse Stock Split

"Peraso Inc. (NASDAQ: PSRO) Pioneers mmWave Technology: The Next-Generation Wireless Communications" see bonus stocks inside…..

Ontrak Health Collaborates with Major Northeast Regional Plan to Bridge HEDIS Care Gaps Using Ontrak Quality Solution

Ontrak Health to Report 2024 Third Quarter Financial Results on November 13, 2024

Ontrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace Populations

Ontrak Health Announces 2024 Third Quarter Financial Results

Ontrak Health Announces New Customer Partnership with Intermountain Health to Deliver Value-Based Behavioral Health Services to Medicare Advantage Members

Ontrak Health and Sentara Health Plans Execute Three-year Contract Extension Following Several Expansions

Ontrak Health Announces Launch of WholeHealth+ Solution for Intermountain Health

BPTH

LASE

OTRK

PSRO

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

Comments

Ontrak

Noticias

Últimas noticias sobre Ontrak (NASDAQ:OTRK) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL